Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated With Rituximab-CHOP or Rituximab-CVP”

3 trials

Showing 3 of 3 results

Not applicableStudy completedNCT01311232
What this trial is testing

Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

Who this might be right for
Patients With Diffuse Large B-cell Lymphoma or Follicular LymphomaPatients Treated With Rituximab-CHOP or Rituximab-CVP
Samsung Medical Center 600
Large-scale testing (Phase 3)Study completedNCT00877006
What this trial is testing

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
Teva Branded Pharmaceutical Products R&D, Inc. 447
Large-scale testing (Phase 3)Study completedNCT01200758
What this trial is testing

Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 410

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation